Efficacy and safety of ustekinumab as maintenance therapy in ulcerative colitis: Week 44 results from UNIFI

被引：0
|
作者：
Sandborn, W. J. [1 ]
Sands, B. E. [2 ]
Panaccione, R. [3 ]
O'Brien, C. D. [4 ]
Zhang, H. [4 ]
Johanns, J. [4 ]
Peyrin-Biroulet, L. [5 ]
Van Assche, G. [6 ]
Danese, S. [7 ]
Targan, S. R. [8 ]
Abreu, M. T. [9 ]
Hisamatsu, T. [10 ]
Szapary, P. [4 ]
Marano, C. [4 ]
机构：
[1] Univ Calif San Diego, La Jolla, CA 92093 USA
[2] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[3] Univ Calgary, Calgary, AB, Canada
[4] Janssen Res & Dev LLC, Spring House, PA USA
[5] Univ Lorraine, Nancy Univ Hosp, Nancy, France
[6] Univ Leuven, Leuven, Belgium
[7] Humanitas Res Hosp, Milan, Italy
[8] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[9] Univ Miami, Miller Sch Med, Miami, FL 33136 USA
[10] Kyorin Univ, Tokyo, Japan
来源：
JOURNAL OF CROHNS & COLITIS | 2019年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OP37
引用
收藏
页码：S26 / S26
页数：1
相关论文
共 50 条
  • [1] EFFICACY AND SAFETY OF USTEKINUMAB AS MAINTENANCE THERAPY IN ULCERATIVE COLITIS: WEEK 44 RESULTS FROM UNIFI
    Sands, Bruce E.
    Sandborn, William J.
    Panaccione, Remo
    O'Brien, Christopher D.
    Zhang, Hongyan
    Johanns, Jewel
    Peyrin-Biroulet, Laurent
    Van Assche, Gert A.
    Danese, Silvio
    Targan, Stephan R.
    Abreu, Maria T.
    Hisamatsu, Tadakazu
    Szapary, Philippe
    Marano, Colleen W.
    GASTROENTEROLOGY, 2019, 156 (06) : S181 - S181
  • [2] Efficacy and safety of ustekinumab as maintenance therapy in ulcerative colitis: Week 44 results from the UNIFI study
    Sands, B.
    Sandborn, W.
    Pannacione, R.
    O'Brien, C.
    Leong, R.
    Zhang, H.
    Johanns, J.
    Peyrin-Biroulet, L.
    Van Assche, G.
    Danese, S.
    Targan, S.
    Abreu, M.
    Hisamatsu, T.
    Szapary, P.
    Marano, C.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 129 - 130
  • [3] Efficacy and Safety of Ustekinumab (UST) as Maintenance Therapy in Ulcerative Colitis: Week 44 Results from UNIFI
    Marone, Colleen
    Sandborn, William J.
    Sands, Bruce E.
    Panaccione, Remo
    O'Brien, Christopher D.
    Zhang, Hongyan
    Johanns, Jewel
    Peyrin-Biroulet, Laurent
    van Assche, Gert
    Danese, Silvio
    Targan, Stephan
    Abreu, Maria T.
    Hisamatsu, Tadakazu
    Szapary, Philippe
    SWISS MEDICAL WEEKLY, 2019, : 27S - 27S
  • [4] EFFICACY AND SAFETY OF USTEKINUMAB THROUGH WEEK 16 IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS RANDOMIZED TO USTEKINUMAB: RESULTS FROM THE UNIFI INDUCTION TRIAL
    Danese, Silvio
    Sands, Bruce E.
    O'Brien, Christopher D.
    Zhang, Hongyan
    Johanns, Jewel
    Sloan, Sheldon
    Izanec, James L.
    Szapary, Philippe
    Marano, Colleen W.
    Leong, Rupert W.
    Rowbotham, David
    Targan, Stephan R.
    Van Assche, Gert A.
    GASTROENTEROLOGY, 2019, 156 (06) : S1106 - S1106
  • [5] Efficacy and safety of ustekinumab through Week 16 in patients with moderate to severe ulcerative colitis: Results from the UNIFI induction trial
    Danese, S.
    Sands, B.
    O'Brien, C.
    Zhang, H.
    Johanns, J.
    Sloan, S.
    Izanek, J.
    Szapary, P.
    Marano, C.
    Leong, R.
    Rowbotham, D.
    Targan, S.
    Van Assche, G.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 130 - 131
  • [6] Efficacy and safety of ustekinumab through Week 16 in patients with moderate-to-severe ulcerative colitis randomised to ustekinumab: results from the UNIFI induction trial
    Danese, S.
    Sands, B. E.
    O'Brien, C. D.
    Zhang, H.
    Johanns, J.
    Sloan, S.
    Izanec, J.
    Szapary, P.
    Marano, C.
    Leong, R. W.
    Rowbotham, D.
    Targan, S. R.
    Van Assche, G.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S61 - S62
  • [7] Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 4 Years: Final Results of the UNIFI Long-Term Maintenance Study
    Afif, Waqqas
    Arasaradnam, Ramesh P.
    Abreu, Maria T.
    Danese, Silvio
    Sandborn, William J.
    Miao, Ye
    Zhang, Hongyan
    Panaccione, Remo
    Hisamatsu, Tadakazu
    Scherl, Ellen J.
    Leong, Rupert W.
    Rowbotham, David S.
    Peyrin-Biroulet, Laurent
    Sands, Bruce E.
    Marano, Colleen
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (05): : 910 - 921
  • [8] Impact of Response and Inflammatory Burden at Start of Maintenance Therapy on Clinical Efficacy of Ustekinumab Dosing Regimen in UC: Week 44 Results From UNIFI
    Panaccione, Remo
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    Marano, Colleen
    O'Brien, Christopher D.
    Szapary, Philippe
    Zhang, Hongyan
    Johanns, Jewel
    Leong, Rupert W. L.
    Arasaradnam, Ramesh P.
    Rowbotham, David
    Abreu, Maria T.
    Sands, Bruce E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S487 - S488
  • [9] Efficacy and Safety of Maintenance Ustekinumab for Ulcerative Colitis Through 3 Years: UNIFI Long-term Extension
    Abreu, Maria T.
    Rowbotham, David S.
    Danese, Silvio
    Sandborn, William J.
    Miao, Ye
    Zhang, Hongyan
    Tikhonov, Ilia
    Panaccione, Remo
    Hisamatsu, Tadakazu
    Scherl, Ellen J.
    Leong, Rupert W.
    Arasaradnam, Ramesh P.
    Afif, Waqqas
    Peyrin-Biroulet, Laurent
    Sands, Bruce E.
    Marano, Colleen
    JOURNAL OF CROHNS & COLITIS, 2022, 16 (08): : 1222 - 1234
  • [10] Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 4 Years: Final Results From the UNIFI Long-Term Extension
    Sands, Bruce E.
    Abreu, Maria T.
    Danese, Silvio
    Sandborn, William J.
    Miao, Ye
    Zhang, Hongyan
    Panaccione, Remo
    Hisamatsu, Tadakazu
    Scherl, Ellen J.
    Leong, Rupert W.
    Rowbotham, David S.
    Arasaradnam, Ramesh P.
    Peyrin-Biroulet, Laurent
    Afif, Waqqas
    Marano, Colleen
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S525 - S526
12345